Muscle News and Research

RSS

Anti-Aging Institute of California offers 'Don't Pause' to get rid of menopause symptoms

Menopause - it's an unavoidable part of aging as a woman, and brings with it a host of uncomfortable symptoms that negatively impact quality of life. Hot flashes, poor sleep, mood swings, weight gain, night sweats and lethargy are just some of the life-altering symptoms of menopause and perimenopause.

30 Nov 2009

Eli Lilly's Cymbalta receives FDA approval

The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, announced Eli Lilly and Company (NYSE: LLY).

30 Nov 2009

ALS research collaboration receives philanthropic funding

Three prominent philanthropic organizations – The Angel Fund, The ALS Therapy Alliance and Project ALS -- dedicated to finding a treatment for amyotrophic lateral sclerosis (ALS) have financed a new collaboration between one of the world’s leading ALS researchers and RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi).

30 Nov 2009

$Stem cell technology for rapid healing of complicated bone fractures$

Stem cell technology for rapid healing of complicated bone fractures

A novel technology involving use of stem cells, developed by Hebrew University of Jerusalem researchers, has been applied to provide better and rapid healing for patients suffering from complicated bone fractures.

30 Nov 2009

CDS announces second Disability Intensive Course on cerebral palsy

The College of Direct Support (CDS), an internet-based curriculum for direct support professionals and managed in partnership by MC Strategies/Elsevier and the University of Minnesota's Research and Training Center, announced today that its second Disability Intensive Course (DIC) on "Cerebral Palsy" is now available for administrators and learners to use as part of the online curriculum.

30 Nov 2009

Virtual Imaging to showcase Canon’s advanced DR systems at RSNA 2009

Designed to improve today’s routine radiographic procedures, the RadPRO® product line from Virtual Imaging, Inc., a Canon U.S.A., Inc. subsidiary, will feature Canon’s current line of advanced portable and general digital radiography (DR) systems at the 2009 Radiological Society of North America Annual Meeting (RSNA 2009), taking place at McCormick Place, November 29 – December 3.

30 Nov 2009

Study explores brain's rewiring processes during motor learning

New connections begin to form between brain cells almost immediately as animals learn a new task, according to a study published this week in Nature. Led by researchers at the University of California, Santa Cruz, the study involved detailed observations of the rewiring processes that take place in the brain during motor learning.

30 Nov 2009

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

27 Nov 2009

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

Dr. Sarit Larisch, Head of the Cell Death Research Laboratory in the University of Haifa's Department of Biology, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

26 Nov 2009

UT Southwestern Medical Center to offer NeuRx Diaphragm Pacing System implantation

Physicians at UT Southwestern Medical Center soon will begin implanting a new device designed to improve breathing in patients with upper spinal-cord injuries or other diseases that keep them from breathing independently.

26 Nov 2009

Protein mutation can cause a new form of heart failure

Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.

25 Nov 2009

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.

25 Nov 2009

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

‏Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

25 Nov 2009

Investors details for initial television advertising campaign to be provided by Muscle Flex

Muscle Flex Inc. (www.MuscleFlexInc.com) announced today it is providing investors details for the initial television advertising campaign for the Beagle StepFit Pedometer.

25 Nov 2009

Myasthenia Gravis Alliance receives Global Pharmaceuticals grant to further research and awareness

Global Pharmaceuticals, the generic products division of Impax Laboratories, Inc., today announced their cooperation in awarding a modest grant to Myasthenia Gravis Alliance, also known as Myasthenia Gravis Foundation of Greater New York, Inc., a 501(3)(c) non profit membership corporation, incorporated in the State of New York.

25 Nov 2009

Older adults with chronic musculoskeletal pain face increase risk for falls

Older adults who reported chronic musculoskeletal pain in two or more locations, higher levels of severe pain, or pain that interfered with daily activities were more likely to experience a fall than adults who did not reports these types of pain, according to a study in the November 25 issue of JAMA.

25 Nov 2009

Tibion's PK100 Bionic Leg Orthosis awarded TÜV certification

Tibion, a leading provider of bionic devices for rehabilitation and mobility, announced today it has received TÜV certification for its PK100 Bionic Leg Orthosis. The Tibion PK100 product has been tested and evaluated for compliance with internationally recognized standards for the safety of medical products.

24 Nov 2009

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.

24 Nov 2009

Multidisciplinary pediatric neurosurgery program launched

Responding to a growing need in central and northeast Pennsylvania for highly specialized care of pediatric brain tumors and other central nervous system disorders, Geisinger's Janet Weis Children's Hospital has launched a state-of-the-art and comprehensive pediatric neurosurgery program. The multidisciplinary program is led by pediatric neurosurgeon Amir Kershenovich, M.D., who says he is pleased to accept his challenging role.

24 Nov 2009

Scientists determine how insulin resistant drugs alter core biochemical pathways through systems biology approach

Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.

24 Nov 2009

Muscle News and Research

Anti-Aging Institute of California offers 'Don't Pause' to get rid of menopause symptoms

Eli Lilly's Cymbalta receives FDA approval

ALS research collaboration receives philanthropic funding

Stem cell technology for rapid healing of complicated bone fractures

CDS announces second Disability Intensive Course on cerebral palsy

Virtual Imaging to showcase Canon’s advanced DR systems at RSNA 2009

Study explores brain's rewiring processes during motor learning

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

UT Southwestern Medical Center to offer NeuRx Diaphragm Pacing System implantation

Protein mutation can cause a new form of heart failure

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

Investors details for initial television advertising campaign to be provided by Muscle Flex

Myasthenia Gravis Alliance receives Global Pharmaceuticals grant to further research and awareness

Older adults with chronic musculoskeletal pain face increase risk for falls

Tibion's PK100 Bionic Leg Orthosis awarded TÜV certification

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Multidisciplinary pediatric neurosurgery program launched

Scientists determine how insulin resistant drugs alter core biochemical pathways through systems biology approach

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News